Abstract
Rationale
Epilepsy often coexists with depression. Therefore, the probability of simultaneous treatment with antiepileptics and antidepressants and the possibility of interactions between them are relatively high.
Objective
The effects of acute and chronic administration of mianserin on the protective activity of valproate (VPA), carbamazepine, phenytoin, and phenobarbital were evaluated in the maximal electroshock in mice.
Materials and methods
Animals were subjected to electroconvulsions. Undesired effects were evaluated in the chimney test (motor impairment) and passive-avoidance task (memory deficit). Brain concentrations of antiepileptic drugs were assessed by immunofluorescence.
Results
When given acutely, mianserin (at doses greater than or equal to 20 mg/kg) significantly raised the electroconvulsive threshold. The antidepressant, at the subanticonvulsant doses, enhanced the anticonvulsant action of carbamazepine, phenytoin, and VPA.
Mianserin administered chronically at 30 mg/kg significantly decreased the electroconvulsive threshold. In contrast to acute treatment, the antidepressant at subeffective doses diminished the anticonvulsant activity of VPA and phenytoin. Mianserin given either acutely or chronically did not affect the brain concentrations of antiepileptic drugs, so a pharmacokinetic contribution to the observed interactions is not probable.
Acute and chronic treatment with mianserin and its combinations with antiepileptic drugs did not impair either motor coordination or long-term memory.
Conclusion
Although acute application of mianserin may potentiate the anticonvulsant action of some antiepileptics, its chronic administration can lead to the opposite effect. Therefore, as far as the presented results can be transferred to clinical conditions, the antidepressant therapy with mianserin should be limited or even avoided in epileptic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Altamura AC, De Novellis F, Mauri MC, Gomeni R (1987) Plasma and brain pharmacokinatics of mianserin after single and multiple dosing in mice. Prog Neuro-psychopharmacol Biol Psychiatry 11:23–33
Altenburg SP, Farah MB (1999) Tizanidine protects mice against convulsions induced by lidocaine: involvement of alpha 2-adrenoceptors. Pharmacol Toxicol 84:29–33
Blier P (2003) The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol 13:57–66
Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l’action tranquilisante: le test de la cheminee. Med Exp (Basel) 3:81–84
Borowicz KK, Stepien K, Czuczwar SJ (2006) Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharmacol Rep 58:83–90
Borowicz KK, Furmanek-Karwowska K, Sawicka K, Luszczki JJ, Czuczwar SJ (2007) Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Eur J Pharmacol 567:77–82
Denizbasi A, Özyazgan S, Eskazan E (1999) The effect of tizanidine on maximal electroshock seizures (MES) in mice. Gen Pharmacol 32:513–516
Edwards JG, Glen-Bott M (1983) Mianserin and convulsive seizures. Br J Clin Pharmacol 15(Suppl 2):299S–311S
Edwards J, Wheal H (1992) Assessment of epileptogenic potential: experimental, clinical and epidemiological approaches. J Psychopharmacol 6:204–213
Jackson HC, Dickinson SL, Nutt DJ (1991) Exploring the pharmacology of the proconvulsant effects of alpha 2-adrenoceptor antagonists in mice. Psychopharmacology 105:558–562
Jobe PC (2003) Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 4:S14–S24
Jobe CJ, Browning RA (2005) The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav 7:602–619
Kleinrok Z, Gustaw J, Czuczwar SJ (1991) Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J Neural Transm Suppl 34:85–90
Knobloch LC, Goldstein JM, Malick JB (1982) Effects of acute and subacute antidepressant treatment on kindled seizures in rats. Pharmacol Biochem Behav 17:461–465
Krijzer F, Snelder M, Bradford D (1984) Comparison of the proconvulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. Neuropsychobiology 12:249–254
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose–effect experiments. J Pharmacol Exp Ther 96:99–113
Löscher W, Czuczwar SJ (1987) Comparison of drugs with different selectivity for central alpha 1- and alpha 2-adrenoceptors in animal models of epilepsy. Epilepsy Res 1:165–172
Malatynska E, Knapp RJ, Ikeda M, Yamamura HI (1988) Antidepressants and seizure—interactions at the GABA-receptor chloride-ionophore complex. Life Sci 43:303–307
Pericic D, Strac DS, Vlainic J (2006) Zimelidine increases seizure susceptibility in stressed mice. J Neural Transm 113:1863–1871
Peterson SL, Trzeciakowski JP, St Mary JS (1985) Chronic but nor acute treatment with antidepressants enhances the electroconvulsive seizure response in rats. Neuropharmacology 24:941–946
Pinder RM (1985) Adrenoreceptor interactions in the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect? Acta Psychiatr Scand Suppl 320:1–9
Porecca F, Jiang Q, Tallarida RJ (1990) Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. Eur J Pharmacol 179:463–468
Rosenstein DL, Nelson JC, Jacobs SC (1993) Seizures associated with antidepressants: a review. J Clin Psychiatry 54:289–299
Salzberg MR, Vajda FJE (2001) Epilepsy, depression and antidepressant drugs. J Clin Neurosci 8:209–215
Saxena PR (1995) Serotonin receptors: subtypes, functional responses and therapeutic relevance. Pharmacol Ther 66:339–368
Semenova TP, Ticku MK (1992) Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice. Brain Res 588:229–236
Squires RF, Saederup E (1988) Antidepressants and metabolites that block GABAA receptors coupled to 35S-t-butylbicyclophosphorothionate binding sites in rat brain. Brain Res 441:15–22
Statnick MA, Maring-Smith ML, Clough RW, Wang C, Dailey JW, Jobe PC, Browning RA (1996) Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci 69:1763–1771
Tsuda H, Ito M, Oguro K, Mutoh K, Shirashi H, Shirasaka Y, Mikawa H (1990) Involvement of the noradrenergic system in the seizures of epileptic El mice. Eur J Pharmacol 176:321–330
Venault P, Chapouthier G, De Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature 321:864–866
Wang C, Mishra PK, Dailey JW, Jobe PC, Browning RA (1994) Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3s: a neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine. Epilepsy Res 18:1–9
Acknowledgment
This study was supported by the grant from Lublin Medical University, Poland.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borowicz, K.K., Banach, M., Zarczuk, R. et al. Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Psychopharmacology 195, 167–174 (2007). https://doi.org/10.1007/s00213-007-0878-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-007-0878-9